AEGiS-DMG: HIV/AIDS Barometer Daily Mail & GuardianImportant note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to Daily Mail & Guardian main menu
DonateNow


HIV/AIDS Barometer

Mail & Guardian (Johannesburg) - November 20, 2003


Estimated worldwide HIV infections: 54 761 439 at noon on Thursday November 20, 2003

High cost: Financial constraints were reported to be the most significant barrier to anti-retroviral adherence in patients living with HIV and Aids in Botswana prior to the introduction of free treatment. Reports say that though 54% of the patients said they took their drugs as prescribed, if cost were not a barrier 74% would have been adherent.

Treatment adherence has been closely correlated with viral suppression, while non-adherence has contributed to progression to Aids, the development of multi-drug resistance and death.

The study highlights several problems that will affect decision-making by governments, donors and public health officials throughout the developing world as anti-retroviral treatment is introduced. Decisions about the balance of free treatment provision and cost recovery will need to be taken in the light of evidence suggesting that the cost of treatment is the biggest single determinant of non-adherence in all studies carried out in Africa


031120
MG031107


Copyright © 2003 - Daily Mail & Guardian. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .